title: Regression of atherosclerosis in cholesterol-fed rabbits: effects of fish oil and verapamil.
abstract: Previous studies have shown that either fish oil or verapamil can attenuate the development of atherosclerosis in the lipid-fed rabbit. The present study was designed to evaluate the individual and combined effects of these two interventions on regression. Seventy New Zealand rabbits in seven groups (10 each) were fed a 0.3% cholesterol diet for 10 weeks. Control group C10 was then killed. Control group C20 was fed a 0.3% cholesterol diet and the other five groups were fed a normal diet for an additional 10 weeks. Group F in three treated groups received 2 ml/day of fish oil (Proto-Chol, eicosapentaenoic acid, 180 mg/ml and docosahexaenoic acid, 120 mg/ml) by gavage. Group V received verapamil, 2 g/1,000 ml drinking water, and group FV received both fish oil and verapamil for an additional 10 weeks. Group CF (control for fish oil) received 2 ml/day of water by gavage and group CV (control for verapamil) received water without gavage for an additional 10 weeks. The percent of aortic and pulmonary atherosclerosis was measured by planimetry of sudanophilic lesions. The percent of aortic lesions in the four control groups (C20, C10, CF and CV) was 57 +/- 22, 40 +/- 15, 40 +/- 14 and 33 +/- 25%, respectively. The fish oil or verapamil groups (F, V, FV) showed a significant reduction in aortic lesions: 15 +/- 17%, p less than 0.05; 16 +/- 12%, p less than 0.05; and 26 +/- 24%, p = NS, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)
authors: Department of Medicine, University of California, San Francisco.
authors: B Q
authors: BQ
authors: Zhu
authors: R E
authors: RE
authors: Sievers
authors: W M
authors: WM
authors: Isenberg
authors: D L
authors: DL
authors: Smith
authors: W W
authors: WW
authors: Parmley
mesh_terms: D000818:Animals; D001011:Aorta / Q000473:pathology; D001161:Arteriosclerosis / Q000209:etiology / Q000473:pathology / Q000628:therapy*; D002791:Cholesterol, Dietary / Q000009:adverse effects*; D004036:Diet, Atherogenic; D004281:Docosahexaenoic Acids / Q000627:therapeutic use; D015118:Eicosapentaenoic Acid / Q000627:therapeutic use; D005395:Fish Oils / Q000627:therapeutic use*; D008297:Male; D011651:Pulmonary Artery / Q000473:pathology; D011817:Rabbits; D014700:Verapamil / Q000627:therapeutic use*
chemical_list: D002791:Cholesterol, Dietary; D005395:Fish Oils; D004281:Docosahexaenoic Acids; D015118:Eicosapentaenoic Acid; D014700:Verapamil